from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2627c/-

LFCtreatmentdescriptionclass of inhibitor

0.125

Amikacinug/mL Amikacintranslation

0.217

Cap5-10ug/mL Capreomycintranslation

-0.511

Rox10-50 ug/mL Roxithromycintranslation

-0.244

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.138

Rif0.2-5ug/mL Rifampicintranscription

-0.127

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.772

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.347

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.046

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.160

Clofazimine10-13 ug/mL Clofaziminerespiration

0.016

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.194

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.099

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.094

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.010

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.113

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.710

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.137

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.800

Nigericin50 uM Nigericinrespiration

-0.057

TRC10-150 ug/mL Triclosanrespiration

0.025

TRZ10-25 ug/mL Thioridazinerespiration

0.064

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.943

menadione6-10 ug/mL Menadionerespiration

-0.058

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.245

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.138

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.757

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

5.202

NRP_1Non-replicating persistence stage 1dosRassociated

-0.304

Amp0.2mg/mL AmpicillincellWall

0.070

Cephalexin20-100 ug/mL CephalexincellWall

-0.008

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.052

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.635

EMB10-20 ug/mL EthambutolcellWall

-0.405

Eta12-40 ug/mL EthionamidecellWall

-0.344

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.176

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.286

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.037

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.843

BZA0.12 mg/mL BenzamidearomaticAmides

-0.472

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.437

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.040

H2O24 mM hydrogen peroxideDNAdamaging

-0.373

Levo10 ug/mL LevofloxacinDNAdamaging

-0.129

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.153

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.188

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.007

UVUV-irradiationDNAdamaging

-0.297

ARP41-4 ug/mL Antitubercular compound ARP4?

0.038

Antimycin12.5-50 ug/mL Antimycin A?

-0.661

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.007

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.689

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.433

PA8240.2-2 ug/mL PA-824?

2.782

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.172

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.875

Verapamil50 uM Verapamil?

-0.662

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.846

methoxatin10-20 ug/mL Methoxatin?